Therefore maspin could possibly act as a clinically relevant inhibitor of tumor progression, preventing local invasiveness and further systemic progression of papillary thyroid carcinomas [127,128]. This evidence concerns the gene SERPINB5 and thyroid gland papillary carcinoma.